Clinical Trial Update: Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious Puberty [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluates the efficacy and safety of Leuprolide Acetate 45 mg in subjects with Central precocious puberty. The study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty

Drugs mentioned

• Leuprolide Acetate 45 mg (leuprolide acetate)

Snippet

Sponsor: HanAll BioPharma Co., Ltd. | Conditions: CPP | Phase 4 | Status: RECRUITING